Action Potential Venture Capital - aVenture Asset Manager Research
Location
Palo Alto, CA, US
Founded
2013
Action Potential Venture Capital (APVC) is GSK's dedicated venture fund focused on advancing bioelectronic medicine. APVC invests globally in next-generation peripheral neuromodulation medical devices and enabling technologies. The firm typically participates in Series A, B, and C rounds, with occasional investments in later stages such as Series D, E, and G, as well as private equity rounds.
APVC's portfolio includes notable companies like Cala Health, Cvrx, and Setpoint Medical, which have collectively raised substantial capital. The firm is led by experienced partners who take active roles on the boards of their portfolio companies, providing strategic guidance and leveraging GSK's extensive resources. APVC emphasizes an inclusive and diverse approach to innovation, aiming to bring transformative bioelectronic therapies to patients worldwide.
Action Potential Venture Capital - Portfolio Snapshot
Portfolio activity breakdown across disclosed investments and stages
